Among them, the oncogenic carboxy-terminal binding protein (CtBP) family members are the widely concerned because of their overexpression across an extensive spectrum of solid human tumors, including bladder, breast, ovarian, gastric, prostate, and sarcoma cancer, which have become the main targets for cancer prediction, diagnosis, and treatment11–13. The gene discussed is CTBP1; the disease is cancer.